pds.dailypharm.com/pds/attach.pdf · 본태성고혈압, 퇴행성관절염, 폐결핵 등 만성...
TRANSCRIPT
-
, .
, ,
.
.
, 11 347 .
2008 11 30 .
.
.2009 1
-
1. 3
2. 47
3. 68
4. 81
5. 88
6. 94
7. 101
8. 115
9. 121
10. 180
11. 205
- (7) () 223
-
1. 73
2. 47
3. 23
4. 12
5. 17
6. 8
7. 28
8. 11
9. 83
10. 30
11. 15
347
-
- 3 -
, ,
(1-)
(1-)
1 -
.
-
- 1.
.
1.
-
- 4 -
-
- 2. ,
,
,
.
30
,
15 .
()
, , 181
190
100%
5%
3 - 181 360
5%
( 6
), 361
10% (
7 )
-
- 5 -
2006 21 09 18 ( 13)
- 2006 3 4 0850
09 08
(1)
.
1 - 18( 13)
30% . (2006 2
1 )
- 2006.2.1
18(
13) 09
.
: 200621 20(
15)~09
.
(JS010)
- 1
-
- 6 -
() 1
1
- 20060
5130904
,
- (JS010) ,
CCYYMMDDHHMM
.
( 5)
( 1)
-
1 - 18( 13)~ 09
30%
( 1, 5
)
-
- 7 -
06 3 12()
(AA154050)
(AA154010)
(1)
2007-139(, 2008.1.1)- ,
. ,
.
-
()
.
()
(10%)
.
-
- 8 -
AA254 AA254080
(
8 ),
,
,
(
)
.
1 - 8
1 :
.
-
- 9 -
30
1
-
30 2
1 - 8
: 1.
.
2.
30 1
.
() ()
()
()
-
- 10 -
1
8
,
,
.
, 3
-
()
50%(:AA222) ,
100%
1 -
.
- 1
.
.
: 4. ,
,
49.09
50%
-
- 11 -
100%
.
: 5.
50% (
9 )
(1)
-
-
.
,
(1-
)
-
- 12 -
2
2 1
2 1
-
(1-) 2 1
-
(1-)
1 2 1
1 - 2
1 .
()
(1)2
1 (1)
1 -
. ,
90
-
- 13 -
- ,
2006 3 10 7
2 1
2 1,
1
.
,
, 2 1
.
-
,
1 -
.
-
.
-
-
- 14 -
(1-)
(1-)
-
,
(1-)
(1-)
.
6
6
- 1999 1 1 2005 9
1
9.03
1 - 1
: 6 9.03, 3.61 .
-
- 15 -
6
(1)
-
-
(7)
,
(2) (9)
1 .
(1)
- ,
-
- 16 -
1
()
(1-)
(1-)
-
,
- ,
( )
,
1 -
1 .
-
- 17 -
-
,
, , ,
- (1)
- ,
1
(1-)
1 - (AF100AF400)
,
.
, ,
(2)
-
- 18 -
-
(1-)
-
(1-)
-
()
()
, ,
(1-)
5 1( ) (AA254050)
o 1
- 18( 13)~ 09
30% .
3 6
3 6 3 6
1 3
o 1
- 1 . : 6
9.03 . , ,
1
-
- 19 -
2003 6 20 2007 7 2
18.06
3 6
9.03 9.03
27.09, 1 3
18.06 .
( 6 6, 1
1, 1-3 7
12() 12()
- , 6 1 11
6 3 15 2
3
1 - 1 12() 12
() .
- 0~6 (
1 ), 18~24
( 2 )
50% .
- 06~12 , 12~18
.
-
- 20 -
1
- 2006 4 4
11 4 13 16
, 9
10
1
1
- 1 (64)
-
.
1 15 100%, 16 30
90%, 31 85%
- 100%
- , 34
-
- 21 -
1 15 100%,
16 30 90%,
31 85%
100%
1 15 100%, 16 30
90%, 31 85%
- 31 90% 85%
- 51
, 1 15
100%, 16
30 90%, 31
85%
31 90% 85%
1 - (2 , 9 ,
10 ) 16 30
90% .
- (2, 9, 10) 31
85% .
2
2000-73(2000.12.30)- 2
-
- 22 -
100%
- 5
14
100% 5, 10
100% 3
90%
(1)
(11-)
- () 2008 5 4
-
1 - (-2, -9, -10) 16 30
-
- 23 -
5 7
(54~57)
4 (57
~511) 5
11
,
-
2008 4 3 4 20
(1~15 15, 16~ 30
2 5 )
420 427
1 ~15 7,
10
1~15 15,
16~30 9
90% .
( 8 )
(-2, -9, -10) 31
85% .
( 9 )
-
- 24 -
37
24
(35%)
- 1
(40%),
( 25%),
( 35%)
,
1 -
( 40%), (
25%), (
35%)
.
-
, 24
.
8
,
35%
.
-
- 25 -
AB001
(
2/3-1)
AB001
, 24
.
, 8
,
35% .
- 2003-65(2003.11.13)
2006 1 1 (7-) (7-) (2)
-
2 1, 1
- 2
1 (7[AG111AG413]) .
. (7-): ,
.. (7-)
: , .
-
- 26 -
1 1 (2)
-
4 3 , 3 [7-(4)] [7-(4)]
2006 1 1
64
-
-
( )
(, DRG )
-
- 27 -
() (
),
64
AFB 3
Chest x-ray(CT)
,
, 3 ()
negative .
- 2007-46 (2007.5.28)
6
,
6
- 6
-
,
6
6 121
-
- 28 -
7
1
AB400(, ) AF400
( - , )
- 6 - , ...
(2008.1.1, 1
)
F001() F004(6
) 38-02(6
F004)
F004(6 )
, 236
- 6()
F004
F001 .
64
o 1
-
.
-
- 29 -
( )
1 7
- 7
5%
1 - ()
.
, , , :1 50% , 2 40% , 3 30%
, 4 20% , 5 10% , 6
.
, , :1: 2 10% ,
2: 3 10% ,
3: 4 15%
4 10%,
4: 5 10% ,
5: 6 10%
-
- 30 -
6 15% , 6
:
7: 5% .
6
,
6
- 6
1 -
6
, 6
17 -51 .
3.
.
3
- 2, 2
17 - 51 .
(1) , () : 1 15
2 10~14
-
- 31 -
3 6~9
4 3~5
(2) , () : 1 5
2 3~4
stupor
()
()
-
- coma
stupor
3 - 1,
: 1. ADL 11 , ,
,
2. count , , ,
1 , 2
.
- B. , 1.
, ,
,
.
.
TPN
-
- 32 -
(
)
()
TPN
- route
- (5% 10% D/W )
route
,
TPN
()
()
-
- G. 1. d.
,
, Sengstaken-Blakemore tube
()
-
- G. 2.
,
-
- 33 -
,
[VAS(Visual Analogue
Scale) 10 7 (Faces Pain
Scale) 5 4 ]
(20%) AS111
AS110
, 6, .
-
2006-42
1 .
- -7-
(AG411) (AG412)
5
(AB400) 4
(AG413) 4
.
- -7-
-
- 34 -
()
AB001
, ,
1,000(AB001) .
06-12 , 18-24 50%
,
181 360
5%
( 6
), 361
10% .
( 7 )
1
Y1001 Y0001
(1)
-
1, 2
-
- 35 -
-
1) 1(15 )
2) 2(10-14)
3) 3(6-9)
4) 4(3-5)
(2)
-
-
,
.
-
- 36 -
-
(
11-(4))
- 525 617(24)
24
5,300,
5 7, 6 17
5 7
2,150, 6
17
4,060
1,010
1 -
.
-
1 - 11-(4)
() 7 : 2,150
() 16 20 : 4,060
() 21 25 : 5,300
-
- 37 -
- 1
[11-(4)()]
- 24 19
16
20 [11-(3)()]
, 1 [11-(3)()] 19
1 -
-
.
1 - 11-(3)
() 1 : 650
() 16 20 : 6,510
- 11-(4)
() 5 : 1,650
() 7 : 2,150-
- 7 5
-
- 38 -
5 [11-(4)()]
7 [11- (4)()]
-
(11-(4))
1 -
.
.
(
)
1
.
1
- 1 2 1
(11-(4)())
2
1
-
- 39 -
- 1
(11-(4)()) 2
1
1
[11-(4)()]
- 1
2
[11-(4)()]
.
1 3.
- .(1)
(3) (1)
(
)
1
.
15%
-
- 40 -
- 2001-40(2001.7.1)
1
2
1
-
1
- 1, 3
1 3
1 1
1 3.
- .(3)
1
.
- '0863 '08620
1 -
.
-
- 41 -
, .
- '08420 '08519
'08520
(, )
.
,
,
.
2008-21 (2008.2.25)
1 - 11-(3)
-
- 42 -
'08531
() 11 : 4,930
() 41 50 : 21,660
11 5
.
- '0851 531 5
. (
)
, ,
.
. 1
2
. ,
,
.
1 - 11-(3)
-
- 43 -
,
1 - 14
() 5 : 2,590
- 11-(3)
() 1 :60
1
1
-
- 70mg 1*4
(7) 1*4
(1) 1*4
(01.1.18) - : 65720-76
2001.2.1 1
.
-
- 44 -
(14)
: 1. ,
,
.
2. (
) ( :I10~I13, I15, : E10~E14)
(
: F00~F99, G40~G41,
: A15~A16, A19, : I05~I09,
I20~I27, I30~I52, : I60~I69,
: G00~G37, G43~G83,
: C00~C97, D00~D09, :
E00~E07, : B18, B19, K70~K77,
: N18)
.
,
,
-
(14)
12 ( 2)
- , 3
(14) 3
1
-
- 45 -
,
(14)
, ,
(14)
3. 12
(, 2) .
.
,
(14)
1 -
.
,
.
- ( )
(: I10-I13,I15,
:E10-E14)
-
- 46 -
( :F00-F99, G40-G41,
:A15-A16, A19 :I05-09, I20-I27, I30-I52,
: I60-I69, : G00-G37,
G43-G83, : C00-C97, D00-D09,
: E00-E0, : B18, B19, K70-K77,
: N18)
.
MT001 (): J
AA900
11
AH 200 11
2008-75(2008.7.16)-12012008.7.4)
- MT001() J
:
: ()
J *
- : MT001()
-
- 47 -
1
2 1
- (634, 636 )
2 1
- (675)
2 -
.
2 - 634 [ ]
- 636 [
]
- 675
J
,
( )
2.
-
- 48 -
2 1
1 2
1
- 1
(683) 2
1
2 (2)
.
-
-
CBC
-
, ,
L
- 10%
.
-
- 49 -
()
(I)(
)
() ()
- Wet smear(4), ESR(103)
-
.
Wet smear, ESR
(110), HDL (302)
10%
-
006
2 - 1
: 5.()()
10%
.(
-
- 50 -
006 6 )* () 2
.
2
110
1
,
2 (5)()
,
(), () () 10%
.( 6
)
()
,
( )
10%
-
(-169)
2 - ()
10%
47, 26
-
- 51 -
1
2
2 1
,
1
2
(-244)
3( )
- 2 1
(R)
.
4( )
- 3 ,
,
2
- :
- : (-244)
HDL(-242)
- :
, , ,
, HBsAg,
Triple test(-FP, Estriol,
HCG)
- B
-
- 52 -
e, Be, SGoT, SGPT
(), HBsAg Triple Test
(-FP, Estriol, -HCG)(IgG, IgM)
-
,
[2] 3
8 10(3)
- 7(2)
(9)
2 - 1 4
- 2 7
- 3 10
: 1,2,3 .[, , , , ,
, , pH, , ]
- 9
ABO & Rh
ABO & Rh
- (Z380)
[2]- 3.
-
- 53 -
ABO(201-) & Rh(202-)
.
.
- ()
, -7
()-(9)
,
,
- ,
(122),
122
, 123
CBC
Set
- (371-)
(371-)
2 - 371-
:
.
-
- 54 -
-
(371-)
(371-)
(400-)
(400-)
2 - 400 []
. , ,
.
.
(406)
2 - 406
: .
-
(405)
,
(405)
- (405)
(406)
-
- 55 -
(406) .
,
,
(405-),
(406-)
- (405-)
,
(407-)
(406-) ,
(407-)
- ,
(405-) ,
(407-
) ,
(407-)
2 - 405
.
.
- 406
.
.
.
- 407 ( ), ,
:1. , ,
.
. ,
. ,
-
- 56 -
(406-)
Helicobacter
Pylori
Helicobacter Pylori(415) (
), MALT
-
(761),
(854) H.Pylori H.Pylori
- Helicobacter Pylori
( ), MALT
(low grade gastric mucosa-associated
lymphoid tissue lym phoma)
.
, ,
- (550-)
- (Needle Aspiration)
- , , (550-)
2 2 - 550
.
: , , .
. , ,
.
. 20 40
-
- 57 -
( )
-550 1
C5501
( ) 200% 100%
2 2 - 550
[Paraffin: 1 ]
MMSE( )
(MMSE) (621-) 50%
- (623)
-
(623)
-
(621-) 50% .
(550-)
1 , (770-)
(550-) 1
2 2 - 550 .
-
- 58 -
(854)
- 1 snare
(0.5cm)
(854 766*20% )
(766)
-
0.5cm , 0.5cm
(snare) 770
,
0.5cm
(766)
(854) .
(610) , , ,
,
- Muscle Tonus,
MusclePower, D.T.R
(610)
- (610) (
)
,
, , ,
,
, 1~2
Muscle Tonus,
Muscle Power, D.T.R, Sensory Joint Cordination
.
-
- 59 -
(
)
( ) , ,
- (
636, )
- 634 ( )
Level , 636
( )
Fluid , ,
, ,
-
(656-1)
- (656) (656-1)
671 (E6720), 672
(E6710)
672 (E6710) 671( ) 672()
(2002.12.18. )
(693-) glucose 5
(
2 3 -
1:
-
- 60 -
( 693-)
)
- (371-) 1
(693-)
-
(371-) 1
(693-)
,
- 693
. (693-)
: Glucose 5 .
(673) (672)
- (672)
(673)
(672)
- (673)
( ) 2~3
(
673)
(672)
(672)
.
(675) 3 3 4
1
2 - 675
: 3 3 .
-
- 61 -
2 2 3
1
2 - 681
: 2 2 .
-
- 62 -
N0031002,
N0031003 ,
.
Free T4 Free
T3
Free T3 Free T4
- 1 Free T3
Free T4 Free
T3(330)
- Free T3(330)
,
, Free T4
Free T4(334)
.
Screening
T3, T4, FreeT4, TSH 4
- 1
T3( 329), T4(333), Free T4(
334), TSH(336) T4(333)
Screening 329 (T3),
333 (T4, 334 Free T4), 336
(TSH) 3 .
- 2007-92
(8mm) 770
-(2,249.49)
47 766
770
-
- 63 -
766(835.44)
.
- 2006-31
2
1 CBC
2
2 (5)()
, (),() ()
10% .
( 6 )
()
,
(
)
-550 [Paraffin: 1 ]
(
2 2 - 550
[Paraffin: 1 ]
.
: , ,
.
-
- 64 -
) C5501 2 1
. ,,
.
. 20
40
1
3()
, , LFT
7 3
- ,
-
1.
2.
3.
4.
8.
HgbA1C
832 HgbA1C 3~4 1
1~2 1 HgbA1C 3
1
- 382 Hgb A1C 397 Fructosamine
Hgb A1C 3-4, Fructosamine
2
-
- 65 -
HgbA1C 3 1
Hgb A1C 3-4 ,
Fructosamine 1 ,
3-4
.
(731)
(891)
[2]- 731
.
891
.
(MMSE)
(MMSE) 621 . (MMPI) 50%
150%
2000-73()- 621
50% .
-
- 66 -
- ,
(MMSE) 621 .
(MMPI) 150%
50%
(693) Glocose 5
Glocose 5
(693) 5
1
2 3 - .
Glocose5 .
(EY251) (E6560)
- 1
- (E6560)
.
4 -615
2 3 - [1 ]
-
- 67 -
(1)
4
(F6151)
-
1
- 2 1
2 (2)
.
(PSA)
(PSA) 40 ,
- 40
(PSA) 40
,
-
- 68 -
10%
- ,
10%
3 1 : 1.
10% .
( 70%) ( 30%)
(
30%)
3 (3) 1 2
.
(4) 1 2
( 30%)
( 70%) .
(5) (3)
(
70%) .
CT()
CT() MRI() (CR)
3 - 2
3.
-
- 69 -
MRI(
)
(CR)
(CR)
(Full Pacs)
(CR)
4. (CR)
(HA001) 51.98 . ,
.
MRI MRI
MRI 1.
(MRI)
()
- 2007-46
3 - 2
6.
20% .
2
2 5
3 1 : 3. (
-
- 70 -
50%
100%
)
2
2 50%
5 .
-
1, 2, 2, 1
2 12
[1] 2()
.
(FULL
PACS)
(Full PACS)
Full PACS
(Full PACS)
-
-
(Full PACS)
-
- 71 -
Full PACS
(FULL
PACS)
- Full PACS
(121)
(, 27.08
)
3 1 : 5. (FULL PACS)
1
27.08
2 50%
5 .
C-Arm
C-Arm (101)
- ,
C-Arm
-
3 1 - 101 C-Arm
: .
- C-Arm
101
,
.
-
- 72 -
C-Arm
(101)
-
(49-) C-Arm
(101)
-
(2)
3 2 : 1.
10% .
2. , ,
.
- 245- CT
: , , ,
50%
, ,
CT 160%
- CT 165%
-
- 73 -
-
, , CT
CT (245-)
165%
, , CT
, , , CT CT(245-
) 150%
- CT 200%
- ,
, CT CT(
245-) 200%
3 2 - 245 - Spine CT
: , , ,
50%
(Myelogram)
CT
(MyelOgram) spine CT ,
spine CT -245 2
spine CT(245-) 130%
- (Myelogram) 100% spine CT
- (MyelOgram) spine CT
,
spine CT -245 2
spine CT(
245-) 130% .
-
- 74 -
100% spine CT 130 %
.
-
(Myelogram) 100% spine CT 100%
spine CT
130%
Brain MRI
MRI 1
2 3
50%
, 4 50%
200%
- MRI
100%
- Brain MRI, Brain
- MRI
(
)
1 1
2
50% ,
4 50%
200% .( )
1
-
- 75 -
MRA, Brain diffusion
Brain MRI(246-(1)) 100%,
Brain MRA(246-(7)) 100%,
Brain diffusion(246- (1)) 100%
MRA 100%
MRI 50%
,
.
3 MRI 200% .
- 1 MRI
()50% + MRA() 100% + MRA()
50% MRA 100% MRI
50%
- 1 MRI()
100% + MRA() 50% + MRI(-)
50% MRA 100% MRI
50%
-
- 76 -
CT
CT
CT CT CT
-
CT(245-) CT
(245-) .
32 - CT(245-)
- CT(245-)
- C-Arm
- C-Arm
- 240 300
,
TRASIS II
TRASIS II -
(334-) 60%
3 3
- 334-
:
-
- 77 -
- -
100%
60% .
< >
-
65 70 1 65
1
(fragility)
- (BMI < 18.5) -
- 40
65
65
,
-
-
- 78 -
-
-
( 10%) .
(CT)
- ( HA 4 3 4 )
1*1(721) 350 1*1
350 1*1
3 2
245
-245
(: )
. (1)
()
()
(2)
: HA434() ( )
: HA464
-
- 79 -
(MRI)
(dynamic)
(HE232006) -() 1*1
(HF105006) -(dynamic)
0.5*1 (HF105006) -
(dynamic) 1*1
, dynamic, , MRI
PET() PET( HZ331)
PET(
)
1
-(HZ331) 1*1
-(HZ335) 1*1
-(HZ331) 1*1
-
(HZ336) 1*1
3 3 -335
PET HZ336 :1
2,670.56 .
-
- 80 -
(MRI) 1
100%, 50%
- 100%, 100%
50% .
3 - -. :
50% .
((1), (2), (3))
(1) 2,401.93
(2) 3,431.60
(3) 2,401.93
-
, 7"10" 2
.
3 - -(1)-()
()
(CT)
CT T,
(),
, 23
()
-
- 81 -
- CT()
T, () ,
T,
(),
.
(1-1)
-
(1-1)
4 - 21 5
(
4.
-
- 82 -
-
- 14
)
4 -
.
-
-
- 83 -
55
- 55
- 55:
(1) 1
-
, 16
3
(3) 1
(3) 16
15
4 - 1 215
.
- 1
-4035 1.
,
-
- 84 -
,
- 2007 122 2008 1 20
(1)
2007
AL860
(2008
AL760)
,
.()
- 2008 1.1 30 AL866
(28 39)
(AL828 )
1 - 11 .
-
- 85 -
1 3
4 [] (2) -1
23 4
, 2*31
2008-10(2008.2.1)
,
.
(2008.5.1 )
- -
1.
(,
)
2.
-
- 86 -
Ginkgo Biloba Extract
(, , ) memantine
( ) 1 (
)
.
, 1*31
2*31
2008-10(2008.2.1)
,
.
(2008.5.1 )
- -
1.
(,
)
2.
Ginkgo Biloba Extract
(, , ) memantine
-
- 87 -
( ) 1 (
)
.
100ml
200ml 100ml ()
( 2008-45, 08.6.1)
1.
: () 2.
- 100ml((: ketoprofen lysine)
50ml)
- ,
.
(10mg)
1 20mg( *2) 1
10mg (*1) .
3.(2) (
)
. .
-
- 88 -
-
(1)
6 - ,
2, 9
10
.
, , ()
(9)
(1)
9 - 9
(5-1)
(2)
5 1 - 5-1 : 1 1, 1 2
.
5.
-
- 89 -
(5-1) 1 1, 1 2
- ,
5% 500
(5-1) 2
1
1 (1) 2 1
- 0.5
(1) 2
1
5 1 - 1
-
- 90 -
5%
5 1
1 3 3
1
5 1 - 5-1
) 11 , 12
,
-
(4)
(1)
5 1 - 4 ()
: , , ,
.
[, ,
, , ,
-
- 91 -
, ]
(9)
-
(9) ,
.
(S5341) (KK110)
5 1 - 11 (KK110)
:
.
()
(2)
-
5 1 - 5
(1 )
- 2 [1]
- 5-1
-
- 92 -
(2)
1 1 9 1
-
(9)
(1) (1)
5 1 - 1
- 9
1 (1) (9)
5 1 - 1
- 9
-
- 93 -
-
2 (1) 2
1
5 1 - 1- ( ) 1
1, 1 2 .
.
(2) (5)
5%
(2) (
5)
5 1 - 2 (1)
- 5 [1 ]
(lidocaine) 2007-92()
-
- 94 -
.
(2007.11.1 )
- ,
70
130%
30 %
- ,
,
6
.
6.
-
- 95 -
- 71
(24) 130%
30%
, 6
6 - 8 , 70
30% .
,
, (2-, L1211),
(2-) (2-, L1214)
-
,
,
, (
)
6 - 2
.
6 1 - 2
-
- 96 -
: , , ,
, .
. [1 ]
.
: 1 15 .
(3-) (2)
- (2)
6 1 - 2
: , , ,
, .
. [1 ]
.
: 1 15
.
- 3
: (2) .
1 , 1
15
- 1
15
-
- 97 -
- 2 20
,
(1) 1,
(15) 10
1 4
.
18~09 50%
-
50
%
6 (3)- 18~09
50%
15
15 100%
15 50%
15
100%
1. 2-3
, 15
100%, 15 50%
.
-
- 98 -
-
4 9, 5 8
17 (24)
100% 15 2
50%
2. 2
. , ,
, ,
.
( 2008-125, 2008.11.1)
level
2 level 1 level
2 level
() 50%
- L5~S1
100%,
() 100%
50%
- /(STE)
/
.
1, 3
.
.
.
(1)
() 1 level
-
- 99 -
- 210- (Selective Transforaminal Epidural Block/
Transforaminal Epidural Injection
)
- 210- 22 () 50%
() 2 level
- 1 level 210- , 2 level 22
() 50%
, 3 level (22
100%)
- 2 level , 1 level 210- 22
() 50%
, 2 level 22
() 50% (22
100%)
-
- 100 -
(2) : , ,
.
C-Arm
(Spinal Root Block), (Maxillary Nerve) C- Arm
- C-Arm (Maxillary
Nerve)
(23)
- , -
C-Arm
(Spinal Root Block) ,
(25)
- C-Arm
,
C-Arm
.
22 : Transforaminal epidural block 23 : (Trigeminal ganglion),
(Maxillarynerve),
(Mandibularnerve),
(Pterygo-palatine ganglion)
24 : Brachial plexus block (supraclavicle approach )
25 : (Facet joint), (Sacro-iliac joint),
(Paravertebral spinal nerve root),
Dorsal root ganglion block,
(Post. medial branch block) (Spinal
root block) (Psoas compartment block : blind
-
- 101 -
block )
26- : , ,
1
, 1 1 1
1 2 1
7 1 - 102 (1)
- 106 (1)
(30) 1 1 1 1
3 2
7 4 - 30 (1)
(101) (102) 100%,
50%
100%
7 1 - 101
: 2. (102)
50% .
7.
-
- 102 -
50%
(), , (), (
),
()
- ,
(30)
- (
30)
(), ,
(), (),
()
.
(30)
-
30
.
- (101)
(30)
7
- 101
: 1., .
-
- 103 -
- 30
1
- () (101)
(110)
- 2
2
1
(110)
- -110 :()
( ,
)
, (104) 1 (
)
- 10
- , ,
Spasm 2
, 1, 3
-
- 104 -
3
.
13
N0134 ,
115
MM085
9 1 [ ]- 13
: 115 .
(115) (104)
1
-
(
115) (104)
(104)
1 .
(105) 20
7 1 - 105 (1)
: ,
-
- 105 -
,
20 .
(106) 2
2
-
5 2, 6 3
3
- ,
()
10 ,
1~2 .
,
2 .
7
- 106
:2. (106) 2 (116) 3
(130)
(130-) (106)
(106) (116-
-
- 106 -
)
-
.
- 116 (1)
: 1 , 3
.
.
.
- CPM(Continuous Passive Motion)
(116) .
CPM(Continuous Passive Motion)
CPM (116-)
-
CPM
(116-)
,
(110), (113)
7 2 : 1. , , ,
,
.
- 110
-
- 107 -
- 113
(0.5)
-
( )
1 (
) (
) 1 30 ,
. , ,
3 20 0.5
( ) 1 15
.
() = 1(1
) (
)1(1)
( 2008-31, 2008.5.1 )
127
-
-
- 108 -
.
- -
. : (Myofascial Pain
Syndrome)
. :
. ,
.
. : 3 7
7
, 15
.
. :
101 106
. ,
104
( ), 102
-
- 109 -
,
( 2008-125
(), 2008.11.1)
-
2 7
3
--
-
(-588, 2008.5.06 )
-
- 110 -
set
- 1 5
,
2 ,
1 2
,
1 1 ,
,
1-2 10
1
2
- ,
2
,
, ,
- (, )
,
.
- (, )
2
, 2
, , 1 1
-
( )
3
,
-
1
-
, 1-2 1
-
- 111 -
1 1
- ,
2
, (
), ,
, RoM
spasticity stage 4
-
2
FIM 19
- 13 ,
2
- ,
,
(
+ )
1
- (
good )
(Modified Ashworth scale grade )
- 6
( )
-
- 112 -
7
2
(
, - ,
, ,
)
100%
2
200% 2
200%
100%
7 3 - 127 (1)
: 2. 2
100% .
4.
.
(127)
-
-
- 113 -
,
- : (Myofascial Pain
Syndrome)
-
- (
127) 1
-
.
(127)
1
-
(127)
-
- 114 -
7 4 - 30-1
: 1. , (30)
: 2. 2, 1 1 .
2 5
3
(30-1) (30)
-
-
- 115 -
(1) (1-), (1-), (
1-) 2
- -(1-) 3
1
8 - 1
: 2. ,, 2 .
.
.
.
(1-), (1-), (1-)
- 1
-(1-)
(1-)
(1-)
8 - 1
: 1.,, 2. ,,
2
(-4) 8
8.
-
- 116 -
5
- 26
(4) 23
(4) 3
- 4
(, , , , )
:2. 1, 5
.
3 () (1 2 )
-
8
30
-
11( )
-
- 117 -
1
(1~180, 181~360, 361
)
-
11( )
2~3 10
-
8 - -9
1
65730-24(2001.01.09)
-
- 118 -
-
(,
,
,)
- 1
- (11) 1
8 - 11
: 1. 1 . : 2.,, 1
2
.
.
.
.
, , 2
- (11-), (11-
), (11-) 1
,
,
,
(13)
1 1
23( )
3. :
-
- 119 -
- 1
U .
(239) 2*14 (
13 )
(219) 2*14( 13
)(119) 4*14 (
)(117) 1*14
( )
U
.
. 7.
(13) .
(), (), () (),
(),() 2
- (),(),() 2 .
8 - -1 ()
: 1. (),(),() .
2. (),(),() 2
.
-
- 120 -
- 6 2, 5, 8, 14, 19, 22, 27
7
-1() 1*6
-1() 1*1
-1() 1*6 1 .
8 - -1
()
:
15
.
()
:
15 45 .
()
: ,
45
.
-
- 121 -
18 09
- 1809
18~09
-
16
-
19 30
9 1 - 1809
50% .
.
9.
-
- 122 -
(2-1
(1))
- (),
19
(2-1)
-
(2-1(1))
-
(602)
-
- 123 -
- 20
(14-2-)
-
19 30
(613)
- 15
(227)
-
- 124 -
- 18:10
(543)
-
,
(226)
(18
09)
- 17
-
- 125 -
19
(437)
- 08 10
30
- 1311
(493 497)
, 9 1
-
- 126 -
()
- (2-1 )
-
.
,
- (2-1(1))
- ()
(-2-1(2))
10 (543)
-
9 1 - 543 ()
- 543 10
-
- 127 -
6~7
, 10
1 1 . , ()
10 ,
(
2007-46. 07.6.1)
-
-(557-)
9 1 - 557 [
]
.
.
(2-)
(2-1) (585)
-
-
-
- 128 -
(2-)
(2-1)
(2-1)
-
(-1 )
9 - 2-1
-3605(2004.8.26)- 9
1 (2-1)
,
( 65720-1478, 95.12.22)
,
,
(Foley catheter)
(Dressing) (
2-1)
-
- 129 -
,
1 2
1
9 1 -
.
- 108-1 ()
- 442 ()
- 389-1 ()
(389-1)
1 2 1
- ,
-
9 1 (12)-24
-
.
BSS
- calcium chloride :
-
- 130 -
(BSS)
(BSS )
stitch out .
- 1 stitch out
.
- ( )
.
9 1
-
.
- 1cm
2007-143 ()( : 2008.1.1)
1. :
,
.
-
- 131 -
- -
. , ,
. (, )
. (, )
. 2cm
2. : (Catalog No.),(Gauge),
()
.
=> ( 2006-75)
( ) ( ) ( )
- ( )
12 91- 1
. (Face or Neck)
. (others)
- 2
. (Face or Neck)
. (others)
-
- 132 -
(20) 100%,
(2-) 50%
100%
-
(20) 100%
(2-) 50% .
-
(2-
) (2-1)
9 1 - 2-1 (1)
: 1. .(1)
: ( ),
(2)
: , , .
2003-65(03.12.1 )- 1
,
, ,
-
(2-1-(2))
(2-1(1))
-
- 133 -
(Tracheostomy) (2-1(1)) (2-1)
-
(Tracheostomy)
.
2007-92(07.10.26)-
, ,
( 7 ) ,
3 .
, (2-1) (2-1)
(2-1)
-
(2-1) (2-1(1))
-
- 134 -
3
4 (2-1(1))
1
,
- (
4-1)
2007-77(2007.8.30)4-1 (Nebulizer Treatment
of Lower Airway)
,
.
(9)
(2)
- , (), (), (),
(), (), , ,
-
- 135 -
(14-1)
- (12)
-
(12) (14-1)
2000-73(2000.12.28)-
14-1 ,
2
1 100%, 2 50%
200% ,
2000-73(2000.12.30)-
, ,
-
200%
() ()
-
- 136 -
1
- (14-2)
- (14-2) 1
( )
- 14-2 1
,
2
.
(14-2)
-
- 1
, 2
.
1
1 (2-1(1))
(18-1)
9 - 18-1
: 1.
-
- 137 -
1
1 ,
2
1
-
( 2006-38, 2006.5.25)
,
1
.
- : N0011
-9% , , ,
)
- : N0012 - 9%
, , ,
)
9 - ( 18-1) 1 :
.
-
- 138 -
N0011 - Hand, Foot, Finger or Toe, Face,
Genitalia
- : N0012
( - 9% , , ,
) *2
- : N0053( 1,
10~18%)
9 - ( 18-1) 1 :
.
9% (, , , )
(, , ,
)
1291
- 18-1
18-1-(1)(), , , , (N0011)
18-1-(1)(), , , , (N0012)
2008.1.1
-
- 139 -
Keller operation
(Hallux Valgus) Kelleroperation -
- -(72-), -
(30-), -
(60-) -
(93-) ,
2007-46(2007.6.1 )- (Hallux Valgus)
Keller operation -(72-
) .
Cage
Cage Grade I , 6
MRI 1~2
- 4~5
Cage
(49-(3))100%,
- 6
MRI
1~2
,
- Grade I
-
-
- 140 -
-(46-(3)) 50%
, MRI
- huge central
disc herniation(
)
- : , 12mm
, ,
cage
Cage (Pedicle Screw
System
)
Pedicle Screw System Cage
,
- Pedicle
Screw System Cage
- 4-5 ,
2007-92(2007.11.1)
-
- MRI foraminal stenosis ,
-
,
- huge central
disc herniation
.
-
- 141 -
Pedicle Screw System
Cage
(49-(3)) 100%,
-(46-(3))50%
, MRI
- : , cage
Cage Cage
()
(Artificial Disc)
(Artificial Disc)
- L5~S1
-(49-
(3)) 100%, -(46-
(3)) 50% 100%
2007-77(2007.8.30)- Total Disc Replacement 46 (
)
- : 25~60 6
L4~5 L5~S1
MRI
MRI T2
L4~5
L5~S1 ,
-
- 142 -
-
(T-score -3.0 )
,
,
TDR(Total Disc Replacement)
.
, 2
MRI ( CT )
-
(47)
- 11
7
2007-77 (2007.8.30 )(Vertebroplasty)
- -
1. 2
(, , ,
,
, 80 )
2.
3. Kummell's disease
-
- 143 -
(47)
2
- 2
(47)
MRI
. MRI CT
.
, 3
2007-139(2008.1.1 )47-1 (Kyphoplasty)
-
- 144 -
(Kyphoplasty)
30~60%
-
- 1 (Comp. Fx)
(47-1)
2
30-60%
. ,
60% .
- -
. 3
(, , ,
,
, 80 )
.
. Kummell's disease
(1) MRI CT
(2)
-
- 145 -
6
-
(49-)
-
(49-) ,
6
,
2007-139(2008.1.1 ) (49
, 49 , 49
) .
- -
.
6
,
.
.
, , ,
2007-139(2008.1.1 ) .
-
- 146 -
-
(60-1)
- Closed Pinning
(60-1)*100% Closed Pinning(60-(1))
*25%
- -
1.
.
- :
- : 6cm
, 3cm
.
- 1cm
. ,
.
.
.
.
(1)
() Intra-articular comm. Fx(knee, ankle, wrist,
elbow)
() ,
-
- 147 -
(2)
() (1)
() 6-10
()
2.
60 30
60-1
100%, 2
50% .
3.
-
- 148 -
.
. :
. :
( )
60 60
closed pinning
K-wire C/R (60::)
- (60-1)*100% +
(64)*100%
(64)
(60)*50%
9 - 60
: closed pinning
50% .
Bursectomy
Bursectomy
- ,
2007-46(07.6.1)- Bursectomy
(90)
-
- 149 -
Bursectomy
-(70-)
(90)
.
(70-)
- - (82-)
- 70
( )
(70-)
100% (82)
50%
(82) 100%
- ,
(70-) 100%
(82-) 50%
,
-
- 150 -
100%
(N0031003)
(N0031003)
- (320,000)
2006-38 ,
, (
)
.
Carpal Tunnel Release
Carpal Tunnel Release -(93-) ,
-(93-)
- Carpal Tunnel Release 93
() .
, (neurolysis) 93
( )
.
( 2007-46(), 2007.6.1)
-
- 151 -
(Pedicle Screw System)
Pedicle Screw System
50
- Pedicle
Screw System
- 10~3
Pedicle Screw System
[,
](44-(2)) 100%,
-(49-1-) 50% ,
17
43
-
- (T-score -3)
-
-
-
(1) : 15
40 ,
50 ,
(2)
-
Cage
-
- 152 -
(93) ,
(91)
- ,
,
(91)
-
,
93 (
)
(2000-73(), 2000.12.30)
, 1~2 N0932(93)
N0931(93)
- ,
incision line
,
100%, 2 50%
.
- -
. ,
-
- 153 -
(1) recession, tenotomy
() 91 ,
() 1 100%, 2
150%, 3 200%
3
(2) Release, Lengthening, Z-plasty
()
93
() 1-2 : 93
-
() 3-5 : 93
-
() 6 1
93 10% 200%
(3) Capsulotomy
() 70()
50%
() 2 1
-
- 154 -
(70 50%) 100%, 2
150%, 3 200%
200%
.
(1)
(2) 93
200% ,
.
(3) Master knots of Henry
( 2007-46, 2007.6.1)
RCT(Rotator Cuff Tear) repair N0937[93-1(2)] tear size
3cm N0936[93-1(1)]
SLAP repair N0936[93-1(1)]
: -93-1
1) 93-1 . Acromioplasty
- SLAP (superior labrum from anterior to posterior)
repair
-
- 155 -
N0935(93-1) - Adhesiolysis (severe contracture)
2) 93-1 . (1)
Primary Repair
- RCT(Rotator Cuff Tear) 1 repair
- Bankart repair
- Capsular Shift
3) 93-1 . (2)
with Myoplasty
and Tendoplasty
- RCT 2 repair
- RCT large size(2.5~3cm)
4) RCT repair SLAP repair
(1) (2)
5) RCT repair Bankart repair
.
, Biceps tenodesis distal clavicle
excision
-
- 156 -
.
- (chondroplasty,
debridement ) (subchondral
bone stimulation-abrasion, multiple drilling, microfracture
)
,
100 100
.
- -
: (trauma) (femur condyle)
: 2 10( )
: (outerbridge ~)
(outerbridge~)
50%
-
- 157 -
: 15 ~ 50 : 1 ,
(
) .
( 2003-84, 2004.1.1)
,
- (113)
(95)
9 1 -
.
- Endoscopy Transapproach
,
(113) Polypectomy
(113)
1
- : 102(01021)*2
2007-77( 2007.8.30)- 101 102
100
-
- 158 -
100 (
)(01002)*1
- :
102(01021)*2,
100 (
)(01002)*0.5
.
- -
. 100
: 100
100%, 150%(100%+50%)
. 100
: 100
50%, 200%
- (108)
2008-125(2008.11.1 )- 1. 108
, 3
. ,
-
- 159 -
3 .
2. 108 108-1
2 , (
) 2
2/ .
1
7 2 2 1
2007- 46(2007.6.1)- 102-1 ,
1 .
2 (108), (108-1)
2 (108)
2008-125(2008.11.1 )1. 108
, 3
. ,
-
- 160 -
3 .
2. 108 108-1
2 , (
) 2
2/ .
(114) (105) 114
- (
114) (105)
(105)
2008-46(07.6.1)- 114
105 110
114
- (163) 2 1
-
(163) .
-
- 161 -
(
)
(01650)
G-WIRE 165 .[]
(3)[ ] (01659)
165
. (01650)
- (-
)(01659) :
1. .
2.
guide-wire .
3. .
4. Guide-wire
.
5. surgical
tape .
- ()(01650)
:
1. .
2. .
3.
pulse-string stutre .
4. .
-
- 162 -
5. C-arm portable X-ray
.
2
- 3
(226) 3 1
9 1 - 226
: 2. 2 .
100%, 2 50%
(301-) (
297-) 100%
50%
2007-77(2007.8.30 )297 301
100%, 2
50% .
(365) 2 3
1
- 365 2
(398) (705)
2007-46(07.6.1)- (398)
-
- 163 -
(705) 398
.
(398) 2 4
2
- 398
2 .
-
-(430-1-
) 300% 100%
- -430-1 -(R4305)
1
(427-1) 50%
100%
-
427-1
50%
-
- 164 -
,
-
(427)
- (389-1),
(434) (427)
, .
- (437) (7)
(5)
9 1 - 437
: 1. , , , .
- 437-1
: 1. Uterine Massage, Breast Care, Heat Lamp, Dressing .
2. , ,
(437-1) (2-1(1)) Heat
Lamp
-
- 165 -
- Heat Lamp
1 .
3. 1 Pad 1 1(10
) 1 16.25
.
1 , ,
-
1disc diameter
()
(513) ,
(516)
- , 1disc
diameter()
(513)
(516)
-
1 disc diameter
() 513
,
516 .
, 9 1
-
- 166 -
(516-2)
-
-
(516-2)
(Choroidal Neovascular Membrane)
- 516-2
: 2. .2005-52(05.8.1)
1.
,
.
- -
.
-
- 5,400
- : 5 ( 12
: 3)
. (pathologic myopia)
-
- 167 -
-
3.0
- 5.0
26.5
-
- : 3
( 12 )
2. ( )
,
2 , 2
.
- -
. 2
) )
)
-
- 168 -
)
. 0.4
.
2
2 1
- 2 1
- 1
(525) 2 1
9 -
,
1 .
(540)
(525)
9 1 - 540
- 525
-
- 169 -
- (528) ( 529)
-
528
529
.
-
- ,
,
(546-1),
(511),
(511-1)
2007-92(2007.11.1)-
.
Collagen Implant (Punctal Plug
2007-46(07.6.1 )551-1 (),
-
- 170 -
) (
551-1) 50%
- 100% 50%
(, )
.
- -
.
,
.
.
.
: Collagen implant
(Punctal Plug
)
50%
.
Punctal plug
- Punctal
plug Punctal plug
-
- 171 -
(Punctal Plug )
(1)
(2) ( ,
, , Steven- Johnson syndrome,
)
(3) Punctal Plug
(4)
-
- ,
9 1 -
: .
-
- 172 -
(761-)
(761)
-
(766)
-(770-)
0.5cm
, 2 1
20%
(100%)
- 0.5cm 2
(770-
) 150% 30%
9 1 - 770-
: 1 20% (
100% )
2007-46(2007.6.1)
0.5cm
, 0.5cm (snare)
770
, 0.5cm
0.5cm
-
- 173 -
- 0.5cm
(770-)
766 854
.
-
-
(750)
(70)
- Endoscopy(, ,
)
8
9 2 -
-
- 174 -
- 6
(602)
3 2 1
- 13
(603)
4 2
1
- 32
(605)
4 5
.
(4 4)
8
602 [ ] 2 1
603 [ ] 1 1
605 [ ]
. without walker 4 3
. with walker 5 4
606 [ ]
. without walker 2 2
. with walker 3 2
. 4 3
: 8 , 602, 603 3 4
.
-
- 175 -
1
- 52
(606-)
4 3
1
Splint
Roll
Splint Roll 8
- Splint Roll
Splint
Roll
- 9
-(615--without walker)
Splint Roll 85cm
Splint Roll
( : cm)
8
615- [ ](Long Arm Splint) 70 45
615- [ ](short Arm Splint) 40 30
615- [ ](Long leg splint) 120 70
615- [ ](Short Leg Splint) 80 50
-
- 176 -
25cm
- 7 -
(615-) Splint Roll 70cm
25cm
()
() () ()
(613)
-
()
9 2 - 613
:1. .
, Auto Bone Graft
2000-73 31
-
- 177 -
(31)
(69-1)
()
2
, 2
50%
- ()
*2
*0.5
2007-77(07.8.30) 101 102
100
.
- -
. 100
: 100
100%, 150%(100%+50%)
. 100
: 100
50%, 200%
Nasal packing
Nasal packing
2008-110(08.10.1)Nasal packing
-
- 178 -
- (100-1) IVALON
,
,
.
- -
1.
. (Sinus Surgery)
.
(Submucosal Resection or Septoplasty)
.
(Inferior Turbinectomy or Submucosal Inferior
Turbinectomy)
. (Nasal Polypectomy)
. (Caldwell-Luc operation)
-
- 179 -
. (Control of Epistaxis)
. (Endoscopic
Dacryocystorhinostomy)
. (Transnasal Excision
of Pituitary Tumor)
.
2. 2
7
( )
206 205
(2007-139, 2007. 12. 27)
-
,
- 206
205
(. .
) 206
.
-
- 180 -
205
-
205
200% 100%
205 -
-
4 205(1) 1~3 200% 205
(2) 100%
1291
- 205 -
: 1 4"4" . (1) 1 ~ 3
(2) 4 ~ 6
(3) 7
10.
-
- 181 -
Bromocryptine Mesylate( : )
-
Etodolac Aspirin
1 1
- Etodolac Aspirin
- Ketorolac tromethamine 2 ,
16
- Talniflumate 12
- Zolpidem 18
- Topiramate 2
Ketorolac tromethamine 16
10
Talniflumate 12 9
Zolpidem 18 14
Topiramate 2
-
- 182 -
1
Fluticasone Propionate 2
9
2
, 2 2
1
1
[1]
- 2 ()
1 ()
.
3
, 3
2
1
- , ,
,
,
-
- 183 -
2
( ) 3
, 6
1
, ,
- ,
- ,
,
-
100
(, )
100
100
- (,
)
100
-
- 184 -
-
300ml
100
200ml
(, [ketoprofen lysine] 50ml)
-
- Rosiglitazone
Maleate
( :
)
1 Biguanide 1
-
-
Biguanide
1 Biguanide 1
- : 1 4mg
- ,
, 18 , , ,
-
-
- 185 -
- Gabapentin
, Gaba- pentin ,
Gabapentin
-
1. (Epilepsy) -
2.
1) (Diabetic neuropathy)
2) (post-herpetic neuralgia)
3) (spinal cord
injury)
4) (CRPS, Compelx regional
pain syndrome)
5) ,
6) (post spinal surgery
syndrome)
7) (,
)
8) (1
-
- 186 -
-
)
9)
-
-
- Melilotus ext.
, Melilotus ext. ,
Melilotus ext.
[1]
-
.
< Melilotus ext. ( : ) >
- ( )
, , , ,
-
- 187 -
Melilotus ext. - (, , , ),
, ,
- , ,
- ,
, ()
- 2
[1]
-
()- (), .
-
,
-
- 188 -
4 2
()- 2 , 1
90mg, , 50kg
60mg .
-
200mg
propofol ( 2001-28)
1.
,
100 100
- -
- 30 2
- , , ,
, ,
(, 1010mg/kg/hr,
10 8mg/kg/hr, 6mg/kg/hr
-
- 189 -
)
- 120mg/12ml/Amp 1
2.
(propofol )
propofol 120mg/12ml/Amp 1 -
()
120mg/20ml/Amp
- propofol 30 2
,
(,
10 10mg/kg/hr, 10 8mg/kg/hr,
6mg/kg/hr ),
120mg/12ml/Amp 1
(
)
- ,
4mg/kg/hr
Methocarbamol 3
-
- 190 -
( :
)
-
3
3
- : 1 500
. 1 1g, 1 3g
3
. ,
48 .
memantine ( : )
( )
memantine MMSE 20
CDR 2~3 GDS stage 4~7
- memantine
- MMSE 20 CDR
1
- MMSE 20 GDS
stage 3
- memantine (
)
6-12
,
MMSE 20 CDR 2~3 GDS
stage 4~7
- acetylchoinesterase inhibitor(donepezil,
galantamine, rivastigmine ) Ginkgo Biloba
Extract 1
Celecoxib ( :
Celecoxib
Celecoxib ( : )
-
- 191 -
) - Celecoxib
,
.
,
- -
1. , ,
2. Steroid
3.
4. NSAID
5. NSAID
6. 65
(CABG)
( )
()
-
- 192 -
()-
100 100 .
,
Ginkgo Biloba Extract
( :
)
Ginkgo Biloba Extract
-
- Ginkgo Biloba Extract ( :
)
,
- -
1.
(,
)
2.
Ginkgo Biloba Extract
(, , ) memantine
-
- 193 -
( ) 1 (
)
.
Pregabalin pregabalin ( ) ,
- ,
- pregabalin ()
,
.
- -
1. (Epilepsy) -
2.
. : thioctic acid
( -lipoic acid)
pregabalin
.
-
- 194 -
. : lidocaine (
:)
.
.
. (spinal
cord injury)
. (CRPS, Compelx regional
pain syndrome)
eperison HCL ( :
)
(eperison HCL )
-
(, ,
), (,
, ,
, ,
arterial blood insufficiency
1. () , ,
2. (SLR
-
- 195 -
- ,
, )
(, )
Acyclovir( :
)
Acyclovir( : )
- Acyclvir
Acyclovir ( : )
- (
)
B a l o f l o x a c i n 100mg( :
)
100mg 1 2 7 5
Balofloxacin 100mg ( 2007-22)
.
- -
. 3~-5
.
-
: 1 100mg 1 2
( 40ml/min
-
- 196 -
) : 1 100mg 2 1
. ,
- 1 (ofloxacin )
. , ,
,
1 . 7
14 .
- :
Diclofenac Sodium
, Diclofenac Sodium ,
Diclofenac Sodium
[1]
-
.
Diclofenac Sodium - , ( ),
, ,
,
-
- 197 -
14*2 2
2 100100
()- 2
100100
rosiglitazone + metfoormin
( :
)
rosiglitazone + metformin
(2)
-
- rosiglitazone + metformin
(2)
1 rosiglitazone
4(
)
( (), ,
)
.
3.0
1.
-
- 198 -
-
2.3
acute complication( )
3.0
,
3.5
100100
. :
(1) oncotic deficit(
)
(2) plasma or volume
deficit
. : (1) shock, (2) Burns
(3) Adult respiratory distress syndrome
(4) Cardiopulmonary bypass
(5) Hemolytic disease of the newborn
(6) Acute nephrosis
(7) Subacute or chronic hypoproteinemia
2.
-
- 199 -
. volume expansion
5% Angiogram
Doppler, MRI vasospasm(
)
1-1.5g/kg/day 7
,
. osmorality()
1~2(
100/1 )
. Plasma exchange
(Plasma pheresis Eval Filter Albumin
).
. plasmanate 5%
2~3 (
2003-54)
-
- 200 -
-
Hb 10g/
,
- Hb
-
Hb 10g/
,
4~6 .
-
,
4~6 .
Serum Ferritin 12ng/ Transferrin saturation rate 15%
Serum
Ferritin 100ng/ Transferrin saturation
rate 20%
-
Hb 10g/ ,
4 .
- 8
Serum Ferritin 12ng/
Transferrin saturation rate 15%
-
-
- 201 -
-
- Lamivudine
1
.
-
( )
3
-
3
- (, ), raloxifene,
VitD8, Ipriflavon, bisphosphonate
,
3 (QCT 110
/)
-
B Lamivudine HBeAg(+)/HBV-DNA(+) HBeAg
(-)/HBV-DNA(+) SGT SGPT 80
- Lamivudine
- HBeAg(+)/HBV-DNA(+) HBeAg(-) /HBV-
DNA(+) B, ,
SGOT SGPT
80
- Antiviral agent
. B Lamivudine
-
- 202 -
- Acetylcholinest
erase-inhibitor
- Lamivudine
-
Lamivudine
- ALT
Hepatotonics (, )
,
( ) Hepatotonics
Hepatotonics ( )
-
- B
1
, Acetylcholinesterase-inhibitor
MMSE 10~26, CDR
1~2 GDS stage 3~5
- Acetylcho
linesterase-inhibitor
- Acetylcholinesterase inhibitor
,
,
MMSE(mini mental state exam) 10~26
(, 10~24) CDR(clinical dementia
rating) 1~2 GDS(Global Deterioration Scale)
stage 3~5
-
- 203 -
-
-
- Sod. hyaluronate ( )
(Kellgren- Lawrence Grade )
desmopressi acetate (:)
(frequencyvolume chart)
- , ,
- desmopressin acetate (: )
(5 ) () , ( ) (frequency volume chart)
- nasal spray
() ()
, 1
2007-43 - () ()
-
- 204 -
. ,
, ,
( )
.
() 25mg, 50mg
- 1 50mg 50mg 1
- 1 75mg 50mg 1
25mg 1
, 1
. ,
, ,
( )
.
100 100
( ,
, , , , ) 100
100
- 114, 122
, 239 264
-
,
.
- (
-
- 205 -
- 264
NSAIDS
)
- , ,
- diclofenac diethylammonium, diclofenac
epolamine, felbinac, flurbiprofen, indomethacin,
ketoprofen, piroxicam, capsaicin
264
- , , ,
, , .
[1]
-
11.
-
- 206 -
-
()
()
-
10
12
-
.
-
()
, ()
[5]
1
. ,
.
-
CT
.
-
- 207 -
, JS006 ,
- 2
,
,
- , ,
(JS006) ,
[(,
) / ] .
-
,
-
- 208 -
-
,
,
,
,
. ,
.
- 2001.1.1
(
) EDI .
, , ,
1, 3,
8
- , , , (),
, ,
.
() : 1
-
- 209 -
- (A02104311)
8
( : 3
A02104311)
: 2 : 3 , () : 4 : 5 (2000.12.31 ) : 7 : 8
1
- , ,
1 1
3 4
1 3 4 11
- 1
2
1
-
- 210 -
1 1
37 36
AP/Lat 2 10
29
Shoulder AP /Lat/oblique 3(G3302) 7
3(G3303)6
(5) 1
- , ,
5%
1L (KK053)
-
- 211 -
5% 1L 53,
(KK053) 53 5%
1L 52, (KK053)
52
1 5 1 4
2 - 681
: 2 2
.
1 1
-
-
2
9 1 - 2-1 (1)
2-1
:
, , ,
7
1
-
- 212 -
314 (42)
40
-
20ml
20ml 20 19
-
40mg
(
)
- 40mg 40
-
- 213 -
39
-
1g 2
52 50
- 70/30pen(3ml//300)
48 0.48(144)
0.32(96)
-
250mg() 1 5% 1L
()250
, 5% 1L 1
() 249
- 1g
10ml
-
- 214 -
(20ml/) 10
9.5
- 5 17
17 5
17
, 2..
1..()
-
,
.
1 .
- 1
K2053003 K2-053003
- (5
8), (9),
()(8), (8)
.
-
- 215 -
, 8 3
-
8 K2054005
3 K2054005
, ' 28, 29
1,
3, () 4,
8 .
-
[2]
3..
( 47
)
-
- 216 -
-
T0000 AS110()
T0000 AS111( 80/100)
Z9000 AS200
- F001
.
-
- 217 -
-
1
(F001)
- 1
-
- 218 -
(04-05)
20 ,
20(
)
,
(V, W, X
Y ).
: ().
TE
(
)
:
10
,
-
- 219 -
- ,
(13)- (6) + 0 + (6)
- MT019
-
- 223 -
, ,
1 02) 3772-88412 02) 3772-88713 02) 3772-89014 02) 3772-8931
, 1 051) 630-40612 051) 630-4077
, 1 053) 750-94012 053) 750-9360
, 1 062) 605-28112 062) 605-2861
, 1 042) 600-70732 042) 600-7081
2 031) 259-1442~14493 031) 259-1471~1480
, 1 055) 239-7651~76592 055) 239-7666~7674
-
- 224 -
FAX
()
()EDI /
(, ) (, )
, , ,
3772-8815, 88143772-88143772-88093772-8803, 063772-8802, 07, 08, 16, 183772-88193772-88043772-8805
782-1745782-1745782-17453775-0838782-2948782-2949782-1745782-2948
EDI, (S/W )
3772-8833~43772-8835, 8838
782-1467
1
: , , : , , : , , : , : , , , : ,
3772-8862~65
3772-8857~83772-88613772-8854~6
3772-8850~3
3775-0837
7
: , , 5 120 [( : ) 14, 24, 25] : 100-704
-
- 225 -
FAX
2
: , , ,, , , ,
: , : , , , ,
, , : , : , ,
3772-8885~8
3772-8881~4
3772-8889, 90, 93~94
3775-0839
3
: , , , ,
: , , : , , , , : , , : , , , : , , : , , DRG
3772-8913~5
3772-8920~2
3772-8917~9
3772-8917~93772-8902~3
3772-8965
4
: , , , : , , : , , , , : , : , , , , : , : , ,
3772-8945~7, 8955
3772-8948~50
3772-8941~4
3772-8941~50
3772-8963
-
- 226 -
(DDD : 051) FAX
() , EDI,
EDI (, )
630-4017~8630-4016630-4017630-4018630-4023~7630-4003, 630-4005~6, 4013
630-4019
630-4029637-2031
1
DRG, ,
( 1 ,2 ,5)( 0, 8), , , , , , , , , , ( 1,3,5)( 2, 4, 5), , ( 8, 9)( 3, 4, 7), , , , , , , , , , ( 4, 7)( 6, 7)
630-4056~7630-4042630-4045630-4039, 4043
630-4081, 4048630-4061, 4067
630-4046, 4065630-4063, 4064
630-4030
: , 1 877-2(14, 15) : 614-718
-
- 227 -
(DDD : 051) FAX
2
()
( 3, 4, 6)( 5, 6), , , , , , , , , , ( 0, 8, 9)( 3, 8), , , ,
( 0, 7)( 1, 2, 9), , , , , , , , , , ( 2, 6)( 0, 1, 9)
630-4053~5630-4047, 4066630-4044630-4034630-4076~9
630-4072~5
637-2029
-
- 228 -
(DDD : 053) FAX
()
,
EDI
,
, ,
750-9310~9311
750-9320
750-9311
750-9309, 9312, 9319
750-9311
750-9303
741-6876
1
(, , , )
:
:
:
, ( )
750-9366~9, 9402~8
750-9344
750-9342,9345
750-9342
750-9353~5
741-5216
2
(, , , )
:
:
:
, , ( )
750-9351~2, 9362~5
750-9346
750-9356
750-9349
750-9335~9
741-5216
: , 2 100( 2) : 700-082
-
- 229 -
(DDD : 062) FAX
(), EDIEDI (, ), ,
605-2711605-2768605-2712~15605-2760605-2711
529-8027529-8293~4
1
: , , , , , : , , ,
() : , , , , ,
, , : , , , : , , , ,
, : , ,
, (-), DRG
605-2820~22
605-2825~26
605-2830~32
605-2835~36605-2847605-2843~44605-2841~42605-2848~49
529-8296
: , 1608-8 : 506-813
-
- 230 -
(DDD : 062) FAX
2
: , , , , ,
: , , , : , , , ,, ,
, , : , , , : (), , , ,
: , , , , , : , , , : , , , , : , , , () : , , , , ,
: , , , , , , , , , ,
,
605-2870~71
605-2875~76
605-2880~81
605-2890~92605-2893605-2885~86
529-8295
-
- 231 -
: 1380-1( 4) : 302-831
(DDD : 042) FAX
()() EDI
600-7022600-7031
525-5184488-2633
(, ), EDI ( )
600-7014~9600-7021 525-5184
488-2633
1
, : , , , , ,
: , , , , , ,
, ,
600-7064~7
600-7069~73600-7054~6600-7057~9
525-2634
2
, : , , , ,
,
, , , , , , , DRG
600-7080~3
600-7091~4
600-7084~6600-7079600-7060~2
600-7009
-
- 232 -
: 27-10( 5, 6) : 440-831
(DDD : 031) FAX
()
() , EDI (/)EDI, , , ,
259-1401~3259-1413~4259-1404~7259-1422
245-4915246-8142254-9343250-5741
1
DRG()()
259-1437259-1429259-1485259-1481~4259-1450~2
246-0871
2
, , , , , , , ,
, , , , , , , , ,
,
259-1453~6259-1442~9
259-1438, 1440259-1459, 1461259-1460
246-8143
3
, , , , , , , , ,
, , , , , , , (),
(, , )
259-1471~4259-1475~80
259-1492259-1462, 1457259-1493259-1441, 1489
245-9725246-8154
-
- 233 -
: , 7-2( 2) : 641-840
(DDD : 055) FAX
()
, , , , , , EID
239-7603239-7602, 7611~7612,239-7617~7618
239-7678262-0819
EDI,
239-7624239-7601
239-7619
1
() , , , , , , , , , ,
239-7681, 7645239-7648~7649239-7656~7659239-7651~7654
262-1488
2
()DRG, , , , , , , , , ,
239-7644, 7677239-7643239-7663~7665239-7682239-7666~7669239-7671~7674
239-7634
- ) ()01.pdf 1
/ColorImageDict > /JPEG2000ColorACSImageDict > /JPEG2000ColorImageDict > /AntiAliasGrayImages false /CropGrayImages true /GrayImageMinResolution 300 /GrayImageMinResolutionPolicy /OK /DownsampleGrayImages true /GrayImageDownsampleType /Bicubic /GrayImageResolution 300 /GrayImageDepth -1 /GrayImageMinDownsampleDepth 2 /GrayImageDownsampleThreshold 1.50000 /EncodeGrayImages true /GrayImageFilter /DCTEncode /AutoFilterGrayImages true /GrayImageAutoFilterStrategy /JPEG /GrayACSImageDict > /GrayImageDict > /JPEG2000GrayACSImageDict > /JPEG2000GrayImageDict > /AntiAliasMonoImages false /CropMonoImages true /MonoImageMinResolution 1200 /MonoImageMinResolutionPolicy /OK /DownsampleMonoImages true /MonoImageDownsampleType /Bicubic /MonoImageResolution 1200 /MonoImageDepth -1 /MonoImageDownsampleThreshold 1.50000 /EncodeMonoImages true /MonoImageFilter /CCITTFaxEncode /MonoImageDict > /AllowPSXObjects false /CheckCompliance [ /None ] /PDFX1aCheck false /PDFX3Check false /PDFXCompliantPDFOnly false /PDFXNoTrimBoxError true /PDFXTrimBoxToMediaBoxOffset [ 0.00000 0.00000 0.00000 0.00000 ] /PDFXSetBleedBoxToMediaBox true /PDFXBleedBoxToTrimBoxOffset [ 0.00000 0.00000 0.00000 0.00000 ] /PDFXOutputIntentProfile () /PDFXOutputConditionIdentifier () /PDFXOutputCondition () /PDFXRegistryName () /PDFXTrapped /False /Description > /Namespace [ (Adobe) (Common) (1.0) ] /OtherNamespaces [ > /FormElements false /GenerateStructure true /IncludeBookmarks false /IncludeHyperlinks false /IncludeInteractive false /IncludeLayers false /IncludeProfiles true /MultimediaHandling /UseObjectSettings /Namespace [ (Adobe) (CreativeSuite) (2.0) ] /PDFXOutputIntentProfileSelector /NA /PreserveEditing true /UntaggedCMYKHandling /LeaveUntagged /UntaggedRGBHandling /LeaveUntagged /UseDocumentBleed false >> ]>> setdistillerparams> setpagedevice